01530

三生製藥

17.100

+0.530+3.20%
Closed16:09 06/15 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE17.110/17.100
TODAY RANGE16.040-17.180
VOL23.72M
MARKET CAP41.83B
52 WEEK RANGE14.810-36.800
AVG VOL (3M)34.70M
% TURNOVER0.93%
TURNOVER387.93M
P/E (TTM)4.454
% RANGE6.67%
EPS(TTM)3.700
P/E(FORWARD)12.577
P/B1.389
BVPS11.869
DIVIDEND0.250
P/S2.135
BETA--
DIV YIELD1.52%
FREE FLOAT MKT CAP41.83B
SHARES OUTSTANDING2.54B
NEXT EARNINGS08/27-08/31
FREE FLOAT2.54B
LOT SIZE500
EX-DATE07/21/2026
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

三生製藥

01530

+3.20%
17.100

04332

--

00586

--

藥明康德

02359

-1.28%
123.600

凱萊英

06821

-2.21%
90.700

國藥控股

01099

-0.41%
16.930

白雲山

00874

+0.13%
15.230

01513

--

上海醫藥

02607

+1.10%
12.000

復星醫藥

02196

0.00%
16.350

康哲藥業

00867

-3.36%
10.630

06600

--

中國同輻

01763

+6.56%
19.820

W

Wuxi Biologics (Cayman)

02269

-0.51%
30.920

C

China Shineway Pharmaceutical Group

02877

-3.24%
8.070

聯邦制藥

03933

-2.05%
8.580

01681

--

山東新華製藥股份

00719

+0.52%
5.750

同仁堂國藥

03613

+1.49%
6.790

華潤醫藥

03320

-1.45%
4.770

C

CSPC Pharmaceutical Group

01093

+1.52%
7.350

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.